Clinical and Experimental Medicine · Published 2022-02-23 · Journal article · DOI 10.1007/s10238-022-00796-2 · Cited by 1 (Crossref)
Jean-Luc Prétet, Véronique Dalstein, Antoine Touzé, Agnès Beby-Defaux, Patrick Soussan, Élise Jacquin, Philippe Birembaut, Christine Clavel, Christiane Mougin, Alexandra Rousseau, Jean Lacau Saint Guily, G. Agius, S. Albert, E. Babin, J. M. Badet, C. Badoual, A. C. Baglin, K. Blanc-Fournier, E. Cassagneau, C. Debry, D. de Raucourt, M. D. Diebold, X. Dufour, M. Hourseau, R. Lacave, E. Lechapt Zalcman, M. Lefevre, P. Levillain, O. Malard, O. Mauvais, A. Mechine, J. C. Merol, H. Mirghani, S. Morinière, S. Périé, C. Rousselot, T. Simon
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Prétet, J., Dalstein, V., Touzé, A., et al. (2022). High levels of HPV16-L1 antibody but not HPV16 DNA load or integration predict oropharyngeal patient outcome: The Papillophar study. Clinical and Experimental Medicine. https://doi.org/10.1007/s10238-022-00796-2